Neuroprotective properties of nootropic dipeptide GVS-111 in in vitro oxygen-glucose deprivation, glutamate toxicity and oxidative stress
Lab research · 2000
- What was studied
- Cultured cerebellar granule cells; experimental injury models
- Main finding
- GVS-111 showed protective effects in oxygen/glucose deprivation and glutamate/oxidative-stress models; piracetam did not attenuate glutamate toxicity in this experiment.
Study data at a glance
- Participants or experimental model
- Cultured cerebellar granule cells; experimental injury models
- Reported results
- GVS-111 showed protective effects in oxygen/glucose deprivation and glutamate/oxidative-stress models; piracetam did not attenuate glutamate toxicity in this experiment.
Study limitations and source details
Study limitations
- Cell survival is not human clinical neuroprotection.
- The assay-specific piracetam comparison is not a clinical superiority result.
Source details
Indexed primary-paper record and abstract checked; full methods and risk of bias not appraised.
Sources checked
Citation
N. A. Andreeva, E. V. Stel’mashuk, N. K. Isaev, R. U. Ostrovskaya, T. A. Gudasheva, I. V. Viktorov. Neuroprotective properties of nootropic dipeptide GVS-111 in in vitro oxygen-glucose deprivation, glutamate toxicity and oxidative stress Bull Exp Biol Med. 130(10):969–972